Millennium Management’s Pacira BioSciences PCRX Stock Holding History

Millennium Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-25,000	Closed	-$715K	–	6377
2024 Q2	$715K	Buy	+25,000	New	+$712K	﹤0.01%	4361
2017 Q3	–	Sell	-100,000	Closed	-$4.77M	–	3775
2017 Q2	$4.77M	Buy	+100,000	New	+$4.64M	0.01%	1543
2016 Q3	–	Sell	-50,000	Closed	-$1.69M	–	3522
2016 Q2	$1.69M	Buy	+50,000	New	+$2.46M	﹤0.01%	1872

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management's PCRX Position: Q1 2026 in Review

Millennium Management reduced its Pacira BioSciences (PCRX) stake by 53% in Q1 2026, selling an estimated $1.46M and leaving 57,031 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #4196.

Millennium Management first reported a position in PCRX in Q2 2013 and has held it in 48 quarters since. The position peaked at $70.2M in Q3 2018. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.

Millennium Management held 57,031 shares of Pacira BioSciences worth $1.29M as of Q1 2026.
Millennium Management sold 65,575 Pacira BioSciences shares in Q1 2026, an estimated $1.46M.
Pacira BioSciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4196 holding.
Millennium Management first reported a position in Pacira BioSciences in Q2 2013 and has held it in 48 quarters since.
Millennium Management's Pacira BioSciences position peaked at $70.2M in Q3 2018.
241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.